284 related articles for article (PubMed ID: 25950772)
1. Inhibition of Ras signaling by blocking Ras-effector interactions with cyclic peptides.
Upadhyaya P; Qian Z; Selner NG; Clippinger SR; Wu Z; Briesewitz R; Pei D
Angew Chem Int Ed Engl; 2015 Jun; 54(26):7602-6. PubMed ID: 25950772
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a Direct Ras Inhibitor by Screening a Combinatorial Library of Cell-Permeable Bicyclic Peptides.
Trinh TB; Upadhyaya P; Qian Z; Pei D
ACS Comb Sci; 2016 Jan; 18(1):75-85. PubMed ID: 26645887
[TBL] [Abstract][Full Text] [Related]
3. Direct Inhibitors of Ras-Effector Protein Interactions.
Upadhyaya P; Bedewy W; Pei D
Mini Rev Med Chem; 2016; 16(5):376-82. PubMed ID: 26423701
[TBL] [Abstract][Full Text] [Related]
4. The discovery and maturation of peptide biologics targeting the small G-protein Cdc42: A bioblockade for Ras-driven signaling.
Tetley GJN; Murphy NP; Bonetto S; Ivanova-Berndt G; Revell J; Mott HR; Cooley RN; Owen D
J Biol Chem; 2020 Feb; 295(9):2866-2884. PubMed ID: 31959628
[TBL] [Abstract][Full Text] [Related]
5. In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction.
Shima F; Yoshikawa Y; Ye M; Araki M; Matsumoto S; Liao J; Hu L; Sugimoto T; Ijiri Y; Takeda A; Nishiyama Y; Sato C; Muraoka S; Tamura A; Osoda T; Tsuda K; Miyakawa T; Fukunishi H; Shimada J; Kumasaka T; Yamamoto M; Kataoka T
Proc Natl Acad Sci U S A; 2013 May; 110(20):8182-7. PubMed ID: 23630290
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of Ras-SOS Interactions.
Lu S; Jang H; Zhang J; Nussinov R
ChemMedChem; 2016 Apr; 11(8):814-21. PubMed ID: 26630662
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of oncogenic RAS using cell-permeable RAS-binding domains.
Nomura TK; Heishima K; Sugito N; Sugawara R; Ueda H; Yukihiro A; Honda R
Cell Chem Biol; 2021 Nov; 28(11):1581-1589.e6. PubMed ID: 33964212
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a Bicyclic Peptidyl Pan-Ras Inhibitor.
Buyanova M; Cai S; Cooper J; Rhodes C; Salim H; Sahni A; Upadhyaya P; Yang R; Sarkar A; Li N; Wang QE; Pei D
J Med Chem; 2021 Sep; 64(17):13038-13053. PubMed ID: 34415745
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of Ras-Raf association by short peptides.
Barnard D; Sun H; Baker L; Marshall MS
Biochem Biophys Res Commun; 1998 Jun; 247(1):176-80. PubMed ID: 9636675
[TBL] [Abstract][Full Text] [Related]
10. Exceptionally high-affinity Ras binders that remodel its effector domain.
McGee JH; Shim SY; Lee SJ; Swanson PK; Jiang SY; Durney MA; Verdine GL
J Biol Chem; 2018 Mar; 293(9):3265-3280. PubMed ID: 29282294
[TBL] [Abstract][Full Text] [Related]
11. Peptides That Block RAS-p21 Protein-Induced Cell Transformation.
Pincus MR; Lin B; Patel P; Gabutan E; Zohar N; Bowne WB
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831007
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Ral GTPases Using a Stapled Peptide Approach.
Thomas JC; Cooper JM; Clayton NS; Wang C; White MA; Abell C; Owen D; Mott HR
J Biol Chem; 2016 Aug; 291(35):18310-25. PubMed ID: 27334922
[TBL] [Abstract][Full Text] [Related]
13. Design of inhibitors of Ras--Raf interaction using a computational combinatorial algorithm.
Zeng J; Nheu T; Zorzet A; Catimel B; Nice E; Maruta H; Burgess AW; Treutlein HR
Protein Eng; 2001 Jan; 14(1):39-45. PubMed ID: 11287677
[TBL] [Abstract][Full Text] [Related]
14. Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma.
Singh A; Erijman A; Noronha A; Kumar H; Peleg Y; Yarden Y; Shifman JM
J Biol Chem; 2021 Dec; 297(6):101353. PubMed ID: 34717958
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive analysis of RAS-effector interactions reveals interaction hotspots and new binding partners.
Rezaei Adariani S; Kazemein Jasemi NS; Bazgir F; Wittich C; Amin E; Seidel CAM; Dvorsky R; Ahmadian MR
J Biol Chem; 2021; 296():100626. PubMed ID: 33930461
[TBL] [Abstract][Full Text] [Related]
16. Understanding Cell Penetration of Cyclic Peptides.
Dougherty PG; Sahni A; Pei D
Chem Rev; 2019 Sep; 119(17):10241-10287. PubMed ID: 31083977
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction.
Tavassoli A; Lu Q; Gam J; Pan H; Benkovic SJ; Cohen SN
ACS Chem Biol; 2008 Dec; 3(12):757-64. PubMed ID: 19053244
[TBL] [Abstract][Full Text] [Related]
18. Current status of the development of Ras inhibitors.
Shima F; Matsumoto S; Yoshikawa Y; Kawamura T; Isa M; Kataoka T
J Biochem; 2015 Aug; 158(2):91-9. PubMed ID: 26100833
[TBL] [Abstract][Full Text] [Related]
19. Blocking Ras inhibition as an antitumor strategy.
Marín-Ramos NI; Ortega-Gutiérrez S; López-Rodríguez ML
Semin Cancer Biol; 2019 Feb; 54():91-100. PubMed ID: 29409706
[TBL] [Abstract][Full Text] [Related]
20. Conservation and divergence of Grb7 family of Ras-binding domains.
Rajala RV; Rajala A; Gupta VK
Protein Cell; 2012 Jan; 3(1):60-70. PubMed ID: 22271596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
